“My work
lives where structure meets flow,
where research becomes revelation, and where strategy becomes story.”

There's a particular kind of hope that arrives with a first ketamine infusion, or a first psilocybin session. For many people living with Major Depressive Disorder (MDD) or Treatment-Resistant Depression (TRD), it's the first time in years, sometimes ever, that the weight has lifted.

But there's a conversation that doesn't always follow that moment — one that clinicians might not be having, that medical staff don't always know how to approach, and that marketing materials rarely want to touch. It's the conversation about what happens next. When asked directly, clinical staff will be transparent, for the most part. They’ll explain that the therapeutic journey is lifelong, and that psychedelic-assisted therapy is not a magic bullet, nor a promised cure.

There is a tendency to pair psychedelia with something ingested, like a molecule, and perhaps a mind melting experience.
But long before the current psychedelic renaissance found its language in clinical trials and venture capital, there were entire cultural movements that embodied psychedelic thinking without relying on substances at all. Afrofuturism is one of them.

Afrofuturism is often described as a cultural aesthetic that blends science fiction, African diasporic history, and speculative futures. Afrofuturism is also very much a reorientation of perception. It dissolves linear time, reclaims narrative authorship, and constructs alternate realities in which Black identity is expansive, technologically integrated, and cosmically situated. In other words, it does what psychedelics are often said to do: it loosens the grip of inherited structures and opens the door to new ways of seeing.